1. A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Issue 1 (2nd January 2022) Authors: Pirosa, Maria C.; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios Journal: Leukemia & lymphoma Issue: Volume 63:Issue 1(2022) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial. (16th December 2016) Authors: Mey, Ulrich J. M.; Brugger, Wolfram; Schwarb, Heike; Pederiva, Stefanie; Schwarzer, Andreas; Dechow, Tobias; Jehner, Paul; Rauh, Jacqueline; Taverna, Christian J.; Schmid, Mathias; Schmidt‐Hieber, Martin; Doerfel, Steffen; Fischer, Natalie; Ruefer, Axel; Ziske, Carsten; Knauf, Wolfgang; Cathomas,... Journal: British journal of haematology Issue: Volume 176:Number 5(2017) Page Start: 770 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group. Issue 10 (October 2016) Authors: Kreissl, Stefanie; Mueller, Horst; Goergen, Helen; Mayer, Axel; Brillant, Corinne; Behringer, Karolin; Halbsguth, Teresa Veronika; Hitz, Felicitas; Soekler, Martin; Shonukan, Oluwatoyin; Rueffer, Jens Ulrich; Flechtner, Hans-Henning; Fuchs, Michael; Diehl, Volker; Engert, Andreas; Borchmann, Peter Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does progress achieved in the treatment of patients with metastatic non‐small‐cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland. (21st January 2020) Authors: Schmid, Sabine; Suipyte, Jorune; Herrmann, Christian; Mousavi, Mohsen; Hitz, Felicitas; Früh, Martin Journal: European journal of cancer care Issue: Volume 29:Number 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gemcitabine, dexamethasone, and cisplatin (GDP) is an effective and well-tolerated salvage therapy for relapsed/refractory diffuse large B-cell lymphoma and Hodgkin lymphoma. Issue 2 (1st February 2017) Authors: Moccia, Alden A.; Hitz, Felicitas; Hoskins, Paul; Klasa, Richard; Power, Maryse M.; Savage, Kerry J.; Shenkier, Tamara; Shepherd, John D.; Slack, Graham W.; Song, Kevin W.; Gascoyne, Randy D.; Connors, Joseph M.; Sehn, Laurie H. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 2(2017) Page Start: 324 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improved survival of older patients with multiple myeloma in the era of novel agents. Issue 4 (21st April 2015) Authors: Mey, Ulrich J. M.; Leitner, Christoph; Driessen, Christoph; Cathomas, Richard; Klingbiel, Dirk; Hitz, Felicitas Journal: Hematological oncology Issue: Volume 34:Issue 4(2016:Dec.) Page Start: 217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Not everything that looks like a bruise, is a bruise …. (September 2018) Authors: Silzle, Tobias; Hitz, Felicitas; Cogliatti, Sergio; Cozzio, Antonio Journal: European journal of cancer Issue: Volume 101(2018)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Issue 9976 (11th April 2015) Authors: Behringer, Karolin; Goergen, Helen; Hitz, Felicitas; Zijlstra, Josée M; Greil, Richard; Markova, Jana; Sasse, Stephanie; Fuchs, Michael; Topp, Max S; Soekler, Martin; Mathas, Stephan; Meissner, Julia; Wilhelm, Martin; Koch, Peter; Lindemann, Hans-Walter; Schalk, Enrico; Semrau, Robert; Kriz, Jan;... Journal: Lancet Issue: Volume 385:Issue 9976(2015) Page Start: 1418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Issue 4 (11th December 2013) Authors: Hitz, Felicitas; Diem, Stefan; Haile, Sarah R.; Ess, Silvia; Cerny, Thomas; Mey, Ulrich Journal: Hematological oncology Issue: Volume 32:Issue 4(2014:Dec.) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Outcome of older myeloma patients in relationship to comorbidities and availability of second‐generation novel agents in a real‐life setting. Issue 4 (22nd May 2022) Authors: Lalive d'Epinay, Murielle; Güsewell, Sabine; Graf, Nicole; Mey, Ulrich J. M.; Driessen, Christoph; Hitz, Felicitas Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗